
TOMDF
Healthcare · Diagnostics & Research · $21,304 market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 14, 2022 | Time not confirmed | — | -0.00 | — |
| Aug 22, 2022 | Time not confirmed | — | -0.01 | — |
| May 16, 2022 | Time not confirmed | — | -0.01 | — |
| Mar 31, 2022 | Time not confirmed | — | -0.02 | — |
| Nov 15, 2021 | Time not confirmed | — | -0.01 | — |
| Sep 24, 2021 | Time not confirmed | — | 0.01 | — |
| Jun 22, 2021 | Time not confirmed | — | -0.04 | — |
| Mar 31, 2021 | Time not confirmed | 0.00 | -0.04 | — |
| Sep 30, 2020 | Time not confirmed | 0.00 | -0.07 | — |
| Jun 30, 2020 | Time not confirmed | 0.00 | -0.01 | — |
| Mar 31, 2020 | Time not confirmed | 0.00 | -0.03 | — |
Todos Medical Ltd., a vitro diagnostics company, engages in the development of novel blood tests for the early detection of cancer and neurodegenerative disorders. It offers COVID testing solutions and Provista diagnostics. The company also develops Videssa Breast, a cancer blood test; Lympro, an Alzheimer's blood test; TolloTest, a 3CL proteaste test; and TBIA, an AI cancer platform. In addition, it distributes a…